护脉散治疗化疗性静脉炎的疗效观察

Clinical Efficacy Observation of Humai Powder for Chemotherapy Phlebitis

目的:观察护脉散治疗化疗性静脉炎的临床疗效。方法:选择80例发生化疗性静脉炎的恶性肿瘤患者,采用随机数字表法分为治疗组和对照组,各40例。治疗组患者予以护脉散外敷,1 h/次,2次/d;对照组患者采用多磺酸黏多糖乳膏外涂,2次/d。比较两组患者患处静脉疼痛消失时间和红肿消退时间,以及治疗48 h后的总体临床疗效。结果:治疗组患者患处静脉及周围组织红肿及疼痛消退时间较对照组明显缩短,差异有统计学意义(P<0.05);两组患者临床疗效(治愈率+显效率)比较差异无统计学意义(P>0.05),但治疗组治愈率明显高于对照组(P<0.05)。结论:护脉散能迅速缓解化疗性静脉炎患者临床症状并有较高治愈率。

OBJECTIVE：To observe the clinical efficacy of the Humai powder for chemotherapy phlebitis. METHODS：80 patients with chemotherapy phlebitis were randomly divided into treatment group and control group with 40 cases in each group. Treatment group was given Humai powder for external use,1 h/time,2 times/d;control group was given Hirudoid cream for external use,2 times/day. Venous pain,red and swollen disappearance time,and overall clinical efficacy were compared between 2 groups after treatment 48 hours. RESULTS：The time of red and swollen disappearance and pain disappearance in treatment group were shorter than in control group,with statistical significance（P〈0.05）;there was no statistical significance in clinical efficacy（cure rate ＋ significant efficiency）between 2 groups（P〉0.05）,while cure rate of treatment group was significantly higher than that of control group（P〈0.05）. CONCLUSIONS：Humai powder can relieve clinical symptom of patients with chemotherapy phlebitis and has high cure rate.